Literature DB >> 29756662

Existence of Diverse Modifications in Small-RNA Species Composed of 16-28 Nucleotides.

Meng-Dan Lan1, Jun Xiong1, Xue-Jiao You1, Xiao-Cheng Weng1, Xiang Zhou1, Bi-Feng Yuan1, Yu-Qi Feng1.   

Abstract

RNA contains diverse modifications that exert an important influence in a variety of cellular processes. So far, more than 150 modifications have been identified in various RNA species, mainly in ribosomal RNA (rRNA), transfer RNA (tRNA), and messenger RNA (mRNA). In contrast to rRNA, tRNA, and mRNA, the known modifications in small RNA species have been primarily limited to 2'-O-ribose methylation in plants and inosine in mammals. The methylation of small RNAs in mammals is still unclear. Current methods widely used in the characterization of small RNAs are mainly based on the strategy of nucleic acid hybridization and sequencing, which cannot characterize modifications in small RNAs. Herein, we have systematically investigated modifications in small RNAs composed of 16-28 nucleotides (nt) by establishing an effective isolation and neutral enzymatic digestion of small RNAs in combination with liquid chromatography/electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS). This method allowed us to simultaneously detect 57 different types of nucleoside modification. By using this approach, we revealed 24 modifications in small RNAs comprising 16-28 nt from human cells. In addition, we found that the obesity-associated protein (FTO) may demethylate N6 -methyladenosine (m6 A) and N6 ,2'-O-dimethyladenosine (m6 Am) in small RNAs of 16-28 nt. Our study demonstrates the existence of diverse modifications in small RNAs composed of 16-28 nt, which may promote in-depth understanding of the regulatory roles of noncoding RNAs.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  RNA; enzymes; mass spectrometry; modification; neutral enzymatic digestion; obesity-associated proteins

Mesh:

Substances:

Year:  2018        PMID: 29756662     DOI: 10.1002/chem.201801640

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  8 in total

1.  Nucleotide resolution sequencing of N4-acetylcytidine in RNA.

Authors:  Justin M Thomas; Keri M Bryson; Jordan L Meier
Journal:  Methods Enzymol       Date:  2019-03-12       Impact factor: 1.600

Review 2.  Functional Interplay between Small Non-Coding RNAs and RNA Modification in the Brain.

Authors:  Laura J Leighton; Timothy W Bredy
Journal:  Noncoding RNA       Date:  2018-06-07

3.  The epitranscriptome: tools to study, manipulate, and exploit RNA modifications.

Authors:  Anne Yaël Nossent
Journal:  Cardiovasc Res       Date:  2019-11-01       Impact factor: 10.787

4.  N-6-Methyladenosine in Vasoactive microRNAs during Hypoxia; A Novel Role for METTL4.

Authors:  Daphne A L van den Homberg; Reginald V C T van der Kwast; Paul H A Quax; A Yaël Nossent
Journal:  Int J Mol Sci       Date:  2022-01-19       Impact factor: 5.923

5.  RNA marker modifications reveal the necessity for rigorous preparation protocols to avoid artifacts in epitranscriptomic analysis.

Authors:  Florian Richter; Johanna E Plehn; Larissa Bessler; Jasmin Hertler; Marko Jörg; Cansu Cirzi; Francesca Tuorto; Kristina Friedland; Mark Helm
Journal:  Nucleic Acids Res       Date:  2022-05-06       Impact factor: 19.160

Review 6.  Change of Heart: the Epitranscriptome of Small Non-coding RNAs in Heart Failure.

Authors:  Tamar Woudenberg; Nyika D Kruyt; Paul H A Quax; A Yaël Nossent
Journal:  Curr Heart Fail Rep       Date:  2022-07-25

Review 7.  An Emerging Role for isomiRs and the microRNA Epitranscriptome in Neovascularization.

Authors:  Reginald V C T van der Kwast; Paul H A Quax; A Yaël Nossent
Journal:  Cells       Date:  2019-12-25       Impact factor: 6.600

8.  The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells.

Authors:  Sébastien Relier; Eric Rivals; Alexandre David
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.